We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+20.72%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$41.5M
Cap. Flow
+$31.8M
Cap. Flow %
14.78%
Top 10 Hldgs %
55.52%
Holding
68
New
22
Increased
11
Reduced
19
Closed
11

Top Buys

Rank Stock Value
1
QCP
Quality Care Properties, Inc.
QCP
+$11.7M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$10.2M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$8.59M
4
GSK icon
GSK
GSK
+$8.44M
5
AVXS
AveXis, Inc. Common Stock
AVXS
+$6.04M

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$14.1M
2
EHTH icon
eHealth
EHTH
+$4.18M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$4.01M
4
EVHC
Envision Healthcare Holdings Inc
EVHC
+$2.62M
5
PBYI icon
Puma Biotechnology
PBYI
+$2.38M

Sector Composition

Rank Sector Weight
1 Healthcare 75.31%
2 Real Estate 9.99%
3 Miscellaneous 7.87%
4 Industrials 6.33%
5 Financials 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVC
26
DELISTED
Invacare Corporation
IVC
$1.74M 0.81%
99,902
+2,600
+3% +$45.8K
DCPH
27
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.71M 0.79%
+85,090
New +$2.16M
ASND icon
28
Ascendis Pharma A/S
ASND
$16.3B
$1.57M 0.73%
24,054
+11,936
+98% +$671K
PBYI icon
29
Puma Biotechnology
PBYI
$468M
$1.56M 0.72%
22,924
-31,725
-58% -$2.38M
CTRE icon
30
CareTrust REIT
CTRE
$9.22B
$1.47M 0.68%
108,264
-30,000
-22% -$444K
ELV icon
31
Elevance Health
ELV
$85.5B
$1.32M 0.61%
+6,000
New +$1.41M
MDCO
32
DELISTED
Medicines Co
MDCO
$1.3M 0.6%
+39,317
New +$1.23M
IOVA icon
33
Iovance Biotherapeutics
IOVA
$3.63B
$1.1M 0.51%
+65,000
New +$984K
HAE icon
34
Haemonetics
HAE
$4.73B
$1.07M 0.5%
+14,646
New +$1M
CNC icon
35
Centene
CNC
$32B
$1.07M 0.5%
+20,000
New +$1.04M
EHTH icon
36
eHealth
EHTH
$38.4M
$1.07M 0.5%
74,546
-254,009
-77% -$4.18M
EPZM
37
DELISTED
Epizyme, Inc
EPZM
$1.02M 0.47%
+57,449
New +$970K
MGLN
38
DELISTED
Magellan Health Services, Inc.
MGLN
$994K 0.46%
9,282
– –
GBT
39
DELISTED
Global Blood Therapeutics, Inc.
GBT
$860K 0.4%
17,800
-21,000
-54% -$1.17M
ARNA
40
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
$826K 0.38%
+20,900
New +$813K
ALGN icon
41
Align Technology
ALGN
$11.2B
$753K 0.35%
3,000
-1,000
-25% -$257K
AMRN
42
Amarin Corp
AMRN
$295M
$753K 0.35%
+12,500
New +$928K
IRMD icon
43
iRadimed
IRMD
$1.11B
$735K 0.34%
51,059
– –
AFMD
44
DELISTED
Affimed
AFMD
$716K 0.33%
+38,686
New +$730K
BCRX icon
45
BioCryst Pharmaceuticals
BCRX
$2.51B
$711K 0.33%
148,959
-49,360
-25% -$254K
DVAX
46
DELISTED
Dynavax Technologies
DVAX
$596K 0.28%
+30,000
New +$518K
ABUS icon
47
Arbutus Biopharma
ABUS
$1B
$587K 0.27%
117,495
+10,000
+9% +$53K
ALBO
48
DELISTED
Albireo Pharma Inc
ALBO
$587K 0.27%
+18,029
New +$607K
MLNT
49
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$569K 0.26%
+15,367
New +$1.01M
FOMX
50
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$551K 0.26%
+107,500
New +$647K
1
2
3

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Eversept Partners held 68 positions worth $215M, up 24% from $174M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Eversept Partners deployed $31.8M of net new capital in Q1 2018, opening 22 new positions and adding to 11 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 78,893 shares worth $9.4M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 75% a quarter earlier, followed by Real Estate and Miscellaneous.

On the sell side, the largest reduction was Array Biopharma Inc, an estimated $14.1M trimmed.

  • Eversept Partners's largest Q1 2018 buy was Alnylam Pharmaceuticals: 78,893 shares worth $9.4M.
  • Eversept Partners added most to Quality Care Properties, Inc. in Q1 2018, an estimated $11.7M increase.
  • Eversept Partners's biggest Q1 2018 reduction was Array Biopharma Inc, cutting an estimated $14.1M.
  • Eversept Partners fully exited Alexion Pharmaceuticals in Q1 2018, selling an estimated $4.01M.
  • Eversept Partners's ten largest holdings make up 56% of its $215M portfolio in Q1 2018.
  • Eversept Partners opened 22 new positions and closed 11 in Q1 2018.
  • Eversept Partners's portfolio value rose 24% quarter-over-quarter to $215M.

Based on Eversept Partners's 13F filing for Q1 2018, filed 14 May 2018.